Ab Initio proud to be a sponsor of the 2023 ARCS Conference

Ab Initio is pleased to announce it is a sponsor of the 2023 ARCS annual conference from the 6th-8th June 2023 at the Sydney International Convention & Exhibition Centre .

The ARCS Annual Conference is Australia’s premier event for health industry; bringing together professionals from across the sector from government and industry including regulatory affairs, medical affairs through to clinical trials and manufacturing.

Ab Initio is presenting its FastTrack solution that enables innovators to take new therapeutics from concept into early phase clinical trials via its R&D and GMP manufacturing capabilities. Ab Initio has state-of-the-art R&D formulation and manufacturing facilities to offer local industry accesses to quality products for clinical trials.